Treat-and-extend bevacizumab improves vision in treatment of BRVO-related macular edema

Intravitreal bevacizumab administered in a treat-and-extend regimen compared favorably to as-needed injections of ranibizumab in the treatment of branch retinal vein occlusion-associated macular edema, according to a study. “Notwithstand¬ing the retrospective and uncontrolled nature of our study, our data suggest that [intravitreal bevacizumab] delivered in a [treat-and-extend] regimen is a cost-effective strategy that offers excel¬lent visual and anatomic outcomes compared to the PRN ranibizumab strategies employed in phase 3 clinical trials,” the study authors wrote.

Full Story →